Total Payments
$133,158
2024 Payments
$20,394
Companies
15
Transactions
130
Medicare Patients
1,424
Medicare Billing
$174,093
Payment Breakdown by Category
Other$115,469 (86.7%)
Travel$7,821 (5.9%)
Food & Beverage$5,021 (3.8%)
Consulting$4,800 (3.6%)
Education$46.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $115,319 | 53 | 86.6% |
| Travel and Lodging | $7,821 | 13 | 5.9% |
| Food and Beverage | $5,021 | 61 | 3.8% |
| Consulting Fee | $4,800 | 1 | 3.6% |
| Honoraria | $150.00 | 1 | 0.1% |
| Education | $46.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $56,991 | 50 | $0 (2024) |
| Relypsa, Inc. | $38,331 | 40 | $0 (2020) |
| Vifor Pharma, Inc. | $23,269 | 18 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $13,492 | 9 | $0 (2023) |
| Amgen Inc. | $217.35 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $150.00 | 1 | $0 (2019) |
| Medtronic, Inc. | $146.90 | 1 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $124.68 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $119.38 | 1 | $0 (2024) |
| Novo Nordisk Inc | $106.05 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,394 | 16 | AstraZeneca Pharmaceuticals LP ($20,166) |
| 2023 | $35,620 | 30 | AstraZeneca Pharmaceuticals LP ($34,413) |
| 2022 | $27,082 | 23 | Bayer HealthCare Pharmaceuticals Inc. ($12,409) |
| 2021 | $11,137 | 12 | Vifor Pharma, Inc. ($10,990) |
| 2020 | $10,674 | 9 | Relypsa, Inc. ($10,656) |
| 2019 | $11,643 | 13 | Relypsa, Inc. ($11,368) |
| 2018 | $16,503 | 24 | Relypsa, Inc. ($16,261) |
| 2017 | $103.76 | 3 | Relypsa, Inc. ($46.50) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $119.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $52.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $109.40 | General |
| Category: Inflammation | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $88.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $54.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $942.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $128.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $1,208.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $57.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $126.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $89.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,350.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 321 | 460 | $145,322 | $36,510 |
| 2022 | 9 | 382 | 601 | $183,655 | $46,739 |
| 2021 | 9 | 367 | 627 | $176,941 | $48,040 |
| 2020 | 9 | 354 | 573 | $153,536 | $42,803 |
Total Patients
1,424
Total Services
2,261
Medicare Billing
$174,093
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 85 | 159 | $36,408 | $9,609 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 101 | $37,716 | $8,681 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 77 | $26,159 | $6,891 | 26.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 45 | $23,449 | $5,994 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 18 | $6,924 | $1,798 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 26 | $6,874 | $1,507 | 21.9% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 11 | 16 | $4,006 | $1,043 | 26.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 14 | 18 | $3,786 | $987.48 | 26.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 62 | 152 | $44,556 | $11,449 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 119 | $43,714 | $10,842 | 24.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 88 | 165 | $33,998 | $8,904 | 26.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 39 | $22,323 | $5,831 | 26.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 39 | $15,119 | $3,926 | 26.0% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 15 | 26 | $6,488 | $1,673 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 28 | $7,272 | $1,583 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,748 | $1,460 | 25.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 17 | 21 | $4,437 | $1,072 | 24.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 75 | 171 | $49,248 | $13,815 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 118 | $43,660 | $11,461 | 26.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 83 | 181 | $36,381 | $10,102 | 27.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 37 | $14,097 | $3,840 | 27.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $8,430 | $2,349 | 27.9% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 16 | 33 | $8,019 | $2,169 | 27.0% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 21 | 30 | $6,120 | $1,723 | 28.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 21 | 24 | $6,288 | $1,426 | 22.7% |
About Dr. Khaled Nashar, MD
Dr. Khaled Nashar, MD is a Nephrology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124056122.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khaled Nashar, MD has received a total of $133,158 in payments from pharmaceutical and medical device companies, with $20,394 received in 2024. These payments were reported across 130 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($115,319).
As a Medicare-enrolled provider, Nashar has provided services to 1,424 Medicare beneficiaries, totaling 2,261 services with total Medicare billing of $174,093. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Pittsburgh, PA
- Active Since 06/29/2006
- Last Updated 10/09/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1124056122
Products in Payments
- Veltassa (Drug) $61,601
- FARXIGA (Drug) $34,706
- LOKELMA (Drug) $22,285
- Kerendia (Drug) $13,492
- Soliris (Drug) $150.00
- Integrity (Device) $146.90
- TERLIVAZ (Drug) $124.68
- PREVYMIS (Drug) $119.38
- TAVNEOS (Drug) $109.40
- Parsabiv (Biological) $107.95
- Saxenda (Drug) $106.05
- SAMSCA (Drug) $95.07
- System One (Device) $43.40
- Renal - Non Product Related (Biological) $21.91
- AURYXIA (Drug) $18.23
- Renal - Prismaflex System (Device) $13.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Pittsburgh
Swati Arora
Nephrology — Payments: $122,437
Nephrology $122,437
Dr. Linda Fried, M.d, M.D
Nephrology — Payments: $88,123
Nephrology $88,123
Cary Shiwarski
Nephrology — Payments: $14,955
Nephrology $14,955
Dr. Paul Palevsky, M.d, M.D
Nephrology — Payments: $13,922
Nephrology $13,922
Dr. Linda Belayev, M.d, M.D
Nephrology — Payments: $12,553
Nephrology $12,553
Sandeep Sharma, Md, MD
Nephrology — Payments: $5,618
Nephrology $5,618